OWC Pharmaceutical Research (OWC Pharmaceutical Research) Additional Paid-In Capital : $19.68 Mil(As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Additional Paid-In Capital?

OWC Pharmaceutical Research's quarterly additional paid-in capital increased from Mar. 2019 ($19.35 Mil) to Jun. 2019 ($19.63 Mil) and increased from Jun. 2019 ($19.63 Mil) to Sep. 2019 ($19.68 Mil).

OWC Pharmaceutical Research's annual additional paid-in capital increased from Dec. 2016 ($11.04 Mil) to Dec. 2017 ($16.17 Mil) and increased from Dec. 2017 ($16.17 Mil) to Dec. 2018 ($18.14 Mil).

OWC Pharmaceutical Research Additional Paid-In Capital Historical Data

The historical data trend for OWC Pharmaceutical Research's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Additional Paid-In Capital Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Additional Paid-In Capital

Get a 7-Day Free Trial

8.00

8.53

11.04

16.17

18.14

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Additional Paid-In Capital	Get a 7-Day Free Trial															17.75	18.14	19.35	19.63	19.68

OWC Pharmaceutical Research Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

OWC Pharmaceutical Research Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner

director, officer: CHIEF FINANCIAL OFFICER

CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387